Latest Breaking News On - Antonio breast cancer symposium - Page 9 : comparemela.com

Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health's Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD) | Region

This study, conducted by Jaguar family company Napo Pharmaceuticals in collaboration with Puma Biotechnology, is one of three important studies providing scientific rationale for the use of crofelemer for prevention

Dr McAndrew on the Impact of the KATHERINE Trial in HER2+ Breast Cancer

Nicholas P. McAndrew, MD, MSCE, discusses the impact of the phase 3 KATHERINE trial in patients with HER2-positive breast cancer.

Amid $350M fundraise, 'promising' clinical trial data, Arvinas sets sights on commercial drug launch

Laying the Foundation for an Improved HR+/ HER2- Breast Cancer Treatment Paradigm

Investigators continue to evaluate HER2 expression as well as CDK4/6 inhibitor use for hormone receptor–positive/HER2-negative breast cancer.

Endocrine Therapy Effective Subsequent Advanced Breast Cancer Treatment

Endocrine therapy, particularly when administered in combination with Verzenio (abemaciclib), is effective when compared with chemotherapy among patients with metastatic breast cancer who experienced disease progression on Ibrance (palbociclib), according to recently published research.